Clinical Trial Update: A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before [Phase 3]

View source ↗

Summary

A Phase 3 study compares a new weekly insulin, insulin icodec used with the DoseGuide app, against daily insulins in people with Type 2 diabetes who have not us…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Daily insulins (insulin (daily regimens))
• Insulin Icodec (insulin icodec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2025-08-26